NCAM1 and limb-girdle muscular dystrophy: Tedesco et al. 113 used a similar strategy but went one step further by deriving mesoangioblast-like cells (no CD56 expression) from human iPSCs generated from limb-girdle muscular dystrophy 2D (sub-type of limb-girdle muscular dystrophy) patient fibroblasts or myoblasts.